By Erik Sass, TES Editor-in-Chief As controversy continues to rage about the efficacy of hydroxychloroquine and other drugs against COVID-19, regulators and scientific authorities in the U.S. and abroad have consistently held up randomized controlled trials (RCTs) as the “gold standard” of drug efficacy research – but what if there was actually a way […]
Tag: Clinical trials
Africa must expand its clinical trial capacity
It would be an understatement to say that international coordination to the COVID-19 response has been wanting, with global organizations and national governments frequently at odds and confusion prevailing generally. The problems resulting from this lack of coordination are especially serious in low and middle-income countries (LMICs), notes Patrice Matchaba, Group Head of Global […]
What can drug companies do to combat racial disparities?
In light of the disproportionate toll COVID-19 has taken on ethnic minorities in the United States and elsewhere, public health authorities are making it a top priority to address racial disparities in healthcare provision and medical science. In an insightful new commentary for Politico, Tim Garnett, chief medical officer of Eli Lilly and Company, […]